EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder

Raman Baweja, Daniel A Waschbusch, Lidija Petrovic-Dovat, Ritika Baweja, Balwinder Singh, Manpreet K Singh, James G Waxmonsky

Journal of Affective Disorders · 2026-10 · 410 · 121967

DOI: 10.1016/j.jad.2026.121967 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Affective Disorders, 2026-10. Verfasst von Raman Baweja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Penn State College of Medicine, Hershey, PA, United States. Electronic address: rbaweja@pennstatehealth.psu.edu. Hauptthemen laut MEDLINE: Major Depressive Disorder, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Practice Patterns, Physicians'. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCATS NIH HHS, National Center for Advancing Translational Sciences, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study examined how comorbid major depressive disorder (MDD) influences ADHD treatment patterns and compared the associations between specific ADHD medication classes and clinical outcomes in adolescents and young adults aged 10-24 years. METHODS: This retrospective comparative cohort study analyzed electronic health records from the TriNetX US Collaborative Network (2010-2025). Among 1,026,253 patients with ADHD, 223,665 (21.8%) had comorbid MDD. Propensity score matching yielded balanced cohorts (ADHD-only and ADHD + MDD; 159,259 per cohort). ADHD treatment patterns were assessed prospectively over 12 months. Within the ADHD + MDD cohort, Cox proportional hazards regression examined whether CNS stimulants versus non-stimulants (including bupropion) differed in their associations with suicidality, antipsychotic initiation, mood stabilizer initiation, and intensive healthcare utilization. RESULTS: Compared with ADHD-only, ADHD + MDD was associated with higher overall ADHD medication prescribing, driven primarily by non-stimulants, particularly bupropion (RR 3.75, 95% CI 3.58-3.92), while racial and ethnic minority patients received fewer ADHD medications. New CNS stimulant prescriptions declined following MDD diagnosis (RR 0.92, 95% CI 0.91-0.93), especially in non-psychiatric settings. Among ADHD + MDD, CNS stimulants were associated with more favorable clinical outcomes compared with non-stimulants (aHRs 0.49-0.68). Bupropion demonstrated outcomes broadly comparable to CNS stimulants for suicidality and mood stabilizer initiation. CONCLUSIONS: Comorbid MDD is associated with substantial shifts in ADHD medication prescribing toward non-stimulants, yet CNS stimulants were associated with the most favorable clinical outcomes, with bupropion emerging as a clinically meaningful alternative when a non-stimulant is considered. These findings should be validated in future longitudinal prospective studies and randomized clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Major Depressive DisorderAttention Deficit Disorder with HyperactivityCentral Nervous System StimulantsPractice Patterns, Physicians'HumansAdolescentFemaleMaleRetrospective StudiesBupropionYoung AdultComorbidityChildTreatment OutcomeUnited States

Stichwörter der Autor:innen

ADHDBupropionCNS stimulantsMDDNon-stimulantsPsychopharmacology

Substanzen

Central Nervous System StimulantsBupropion

Autor:innen und Institutionen

  • Penn State College of Medicine, Hershey, PA, United States. Electronic address: rbaweja@pennstatehealth.psu.edu.
  • Penn State College of Medicine, Hershey, PA, United States.
  • Mayo Clinic, Rochester, MN, United States.
  • University of California Davis, Sacramento, CA, United States.

Förderung

  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Baweja, R., Waschbusch, D. A., Petrovic-Dovat, L., Baweja, R., Singh, B., Singh, M. K., & Waxmonsky, J. G. (2026). Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder. Journal of Affective Disorders, 410, 121967. https://doi.org/10.1016/j.jad.2026.121967

Vancouver

Baweja R, Waschbusch DA, Petrovic-Dovat L, Baweja R, Singh B, Singh MK, et al. Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder. Journal of Affective Disorders. 2026;410:121967. doi:10.1016/j.jad.2026.121967

BibTeX
@article{Baweja2026,
  author = {Baweja, Raman and Waschbusch, Daniel A and Petrovic-Dovat, Lidija and Baweja, Ritika and Singh, Balwinder and Singh, Manpreet K and Waxmonsky, James G},
  title = {Treatment patterns and comparative clinical outcomes of ADHD medications in adolescents and young adults with comorbid major depressive disorder},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {410},
  pages = {121967},
  doi = {10.1016/j.jad.2026.121967}
}
Kostenlos starten →